| Particulars |
|
|
|
| Company Name
| Ipca Laboratories Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
25.37 |
B.V. (₹) |
265.60 |
| Sales(₹ Cr.) |
6,166.46 |
NP (₹ Cr.) |
599.93 |
| NP Var% |
23.00 |
Div% |
400.00 |
| CPS(₹) |
33.40 |
EPS (₹) |
23.60 |
| Traded Value(₹ Lakhs) |
83.30 |
52 Week High |
1,758.00 |
| 52 Week Low |
1,061.00 |
Price BSE |
1,332.00 |
| Price NSE |
1,331.00 |
Market Capital (₹ Cr.) |
33,785.79 |
| P/C Ratio |
39.90 |
P/E Ratio |
56.30 |
| Price Vs.BV |
5.02 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
1,662.68 |
| NP(₹ Cr.) |
267.56 |
NP Var % |
96.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
6,394.25 |
| OPM |
20.65 |
NP |
697.62 |
| NP Var% |
43.85 |
EPS |
32.66 |
| PE |
40.77 |
|
|